Get the Stockscreener App
1.85
1.60%
-0.03
After Hours:
1.84
-0.01
-0.54%
Inmed Pharmaceuticals Inc stock is traded at $1.85, with a volume of 33,842.
It is down -1.60% in the last 24 hours and down -19.21% over the past month.
InMed Pharmaceuticals Inc is a Canada based clinical-stage biopharmaceutical company. The Company's operations consist of two operating and reportable segments, the InMed Pharma segment and the BayMedica Commercial segment. The InMed Pharma segment is largely organized around the research and development of small molecule pharmaceuticals drug candidates and the BayMedica Commercial segment is largely organized around manufacturing technologies to produce and commercialize bulk rare cannabinoids for sale as ingredients in the health and wellness industry. Its product portfolio includes INM-755, which is used for the treatment of epidermolysis bullosa; INM-088 for the treatment of glaucoma; INM-901 for Alzheimer's disease.
See More
Previous Close:
$1.88
Open:
$1.89
24h Volume:
33,842
Relative Volume:
0.46
Market Cap:
$3.70M
Revenue:
$4.96M
Net Income/Loss:
$-6.82M
P/E Ratio:
-0.0283
EPS:
-65.4
Net Cash Flow:
$-6.64M
1W Performance:
-9.31%
1M Performance:
-19.21%
6M Performance:
-40.03%
1Y Performance:
-64.49%
1-Day Range:
$1.83
$1.89
1-Week Range:
$1.80
$2.052
52-Week Range:
$1.72
$8.27
Inmed Pharmaceuticals Inc Stock (INM) Company Profile
Name
Inmed Pharmaceuticals Inc
Sector
Phone
(604) 669-7207
Address
1445-885 WEST GEORGIA ST., VANCOUVER
Compare INM with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
INM
Inmed Pharmaceuticals Inc
|
1.85 | 4.48M | 4.96M | -6.82M | -6.64M | -65.40 |
|
ZTS
Zoetis Inc
|
144.35 | 63.86B | 9.39B | 2.62B | 2.22B | 5.8121 |
|
TAK
Takeda Pharmaceutical Co Adr
|
13.42 | 42.46B | 29.96B | 957.25M | 4.77B | 0.2956 |
|
HLN
Haleon Plc Adr
|
9.38 | 41.28B | 14.26B | 1.98B | 2.47B | 0.4327 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
20.52 | 23.49B | 16.70B | -157.13M | 1.19B | -0.1446 |
|
UTHR
United Therapeutics Corp
|
438.66 | 19.18B | 3.08B | 1.24B | 1.07B | 25.61 |
Inmed Pharmaceuticals Inc Stock (INM) Latest News
Is InMed Pharmaceuticals Inc. (MWG) stock protected from inflationWeekly Trading Summary & Fast Gaining Stock Reports - newser.com
Is InMed Pharmaceuticals Inc. stock a buy in volatile marketsJuly 2025 PreEarnings & AI Enhanced Trade Execution Alerts - newser.com
Will InMed Pharmaceuticals Inc. (MWG) stock rise with strong economyPortfolio Return Summary & Long-Term Capital Growth Ideas - newser.com
Is InMed Pharmaceuticals Inc. (MWG) stock considered safe haven2025 Investor Takeaways & Community Consensus Picks - newser.com
How to build a custom watchlist for InMed Pharmaceuticals Inc.July 2025 Setups & High Yield Equity Trading Tips - newser.com
Why pension funds invest in InMed Pharmaceuticals Inc. (MWG) stockJuly 2025 Update & Short-Term Trading Opportunity Alerts - newser.com
How InMed Pharmaceuticals Inc. (MWG) stock expands through international markets2025 Price Action Summary & High Conviction Investment Ideas - newser.com
Is InMed Pharmaceuticals Inc. (MWG) stock a good hedge against inflationQuarterly Trade Summary & Fast Entry High Yield Tips - newser.com
How supply chain issues affect InMed Pharmaceuticals Inc. stockSell Signal & AI Based Trade Execution Alerts - newser.com
Published on: 2025-11-03 04:59:25 - newser.com
Is InMed Pharmaceuticals Inc. stock vulnerable to regulatory risksTrade Entry Report & Fast Entry High Yield Stock Tips - newser.com
Key metrics from InMed Pharmaceuticals Inc.’s quarterly dataQuarterly Investment Review & Capital Protection Trade Alerts - newser.com
What machine learning models say about InMed Pharmaceuticals Inc.Quarterly Growth Report & Expert Curated Trade Setups - newser.com
Comparing InMed Pharmaceuticals Inc. in custom built stock radars2025 Dividend Review & Real-Time Volume Analysis Alerts - newser.com
Will InMed Pharmaceuticals Inc. stock gain from government policiesMarket Trend Report & Capital Efficiency Focused Strategies - newser.com
Will InMed Pharmaceuticals Inc. price bounce be sustainableGold Moves & High Accuracy Investment Signals - newser.com
How sentiment analysis helps forecast InMed Pharmaceuticals Inc.2025 Top Decliners & AI Forecasted Entry and Exit Points - newser.com
What technical patterns form on InMed Pharmaceuticals Inc. (MWG) stock chartsMarket Activity Report & Daily Oversold Bounce Ideas - newser.com
Measuring InMed Pharmaceuticals Inc.’s beta against major indicesJuly 2025 Price Swings & Reliable Price Breakout Signals - newser.com
How strong is InMed Pharmaceuticals Inc. stock balance sheet2025 Earnings Surprises & Entry Point Strategy Guides - newser.com
Published on: 2025-11-02 01:30:40 - newser.com
Long term hold vs stop loss in InMed Pharmaceuticals Inc.2025 Price Targets & Entry Point Confirmation Alerts - newser.com
How InMed Pharmaceuticals Inc. stock performs after earningsQuarterly Profit Review & Verified Momentum Watchlists - newser.com
Published on: 2025-10-31 00:47:28 - newser.com
Is InMed Pharmaceuticals Inc. stock gaining market shareEntry Point & High Accuracy Trade Signal Alerts - newser.com
Published on: 2025-10-30 23:18:49 - newser.com
Published on: 2025-10-30 05:00:46 - newser.com
Published on: 2025-10-29 06:56:17 - newser.com
Inmed Pharmaceuticals Inc Stock (INM) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.35%
0.90%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):